| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 2e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |